Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
University of Rochester
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
Dartmouth-Hitchcock Medical Center
Thomas Jefferson University
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center
University of Utah
University of Rochester
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Loyola University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Albert Einstein College of Medicine
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Nanfang Hospital, Southern Medical University
Roswell Park Cancer Institute
University of Arizona
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
University of Arkansas
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
PETHEMA Foundation
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Baylor College of Medicine
University of Arizona
Barbara Ann Karmanos Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chonnam National University Hospital
University of California, San Francisco
Memorial Sloan Kettering Cancer Center